No abstract available
A new CHA2DS2VASC score integrated with eGFR, left ventricular hypertrophy, and pulse pressure is highly effective in predicting adverse cardiovascular outcome in chronic kidney disease.
Fusaro M;Paoletti E.
2022
Abstract
No abstract availableFile in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2022 Eur J prev - A new.pdf
accesso aperto
Descrizione: A new CHA2DS2VASC score integrated with estimated glomerular filtration rate, left ventricular hypertrophy, and pulse pressure is highly effective in predicting adverse cardiovascular outcome in chronic kidney disease
Tipologia:
Versione Editoriale (PDF)
Licenza:
Altro tipo di licenza
Dimensione
407.59 kB
Formato
Adobe PDF
|
407.59 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
